Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression.

Archivum immunologiae et therapiae experimentalis - 1 Dec 2016

Kandilarova Snezhina Mihailova, Paschen Annette, Mihaylova Anastassia, Ivanova Milena, Schadendorf Dirk, Naumova Elissaveta

Abstract excerpt

Many studies have described the role of killer immunoglobulin-like receptors (KIRs) and their cognate human leukocyte antigen (HLA) class I ligands in the immune protection against melanoma, but the effect of these markers on intra-individual variations in tumor development and progression has remained less clear. We performed KIR, HLA, and KIR/ligand analysis in 283 patients with malignant melanoma in order to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Motifs
Share to Histocompatibility Antigens Class I

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HLA-A3 Antigen

Share to HLA-C Antigens

Share to Killer Cells, Natural

Share to Melanoma, Cutaneous Malignant

Share to Receptors, KIR

Share to Receptors, KIR2DL3

Source

Identifiers

PMID: 28083606
DOI: 10.1007/s00005-016-0437-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression.PMID 28083606Read ↗

KIR gene variability in cutaneous malignant melanoma: influence of KIR2D/HLA-C pairings on disease susceptibility and prognosis.Semantic proximity Read ↗

Computing Skin Cutaneous Melanoma Outcome From the HLA-Alleles and Clinical CharacteristicsSemantic proximity Read ↗

Natural Killer Receptors on CD8 T Cells and Natural Killer Cells from Different HLA-C Phenotypes in Melanoma PatientsSemantic proximity Read ↗

HLA Expression in Uveal Melanoma: An Indicator of Malignancy and a Modifiable Immunological TargetSemantic proximity Read ↗

Computing Skin Cutaneous Melanoma Outcome from the HLA-alleles and Clinical CharacteristicsSemantic proximity Read ↗

Putative linkage between HLA class I polymorphism and the susceptibility to malignant melanoma.Semantic proximity Read ↗

HLA Genotype is Associated With Clinical Outcomes to anti-PD1 Therapy in Advanced MelanomaSemantic proximity Read ↗

Association of inherited variation in Toll-like receptor genes with malignant melanoma susceptibility and survival.Semantic proximity Read ↗

Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells.Semantic proximity Read ↗

Association between cancer risk and HLA genotype can be explained by anti-tumor immunitySemantic proximity Read ↗

Potential prognostic value of PD-L1 and NKG2A expression in Indonesian patients with skin nodular melanomaSemantic proximity Read ↗

Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.